MorphoSys AG is a German biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany, and has a wholly owned subsidiary, MorphoSys US Inc., in Boston, Massachusetts, in the US. From Wikipedia
The acquisition aims to bolster Novartis' cancer treatment offerings, including the promising but controversial pelabresib.
